ulixertinib,bvd-523
biomed valley discoveries
['match trial', 'ulixertinib']
results at #asco22 on #pediatricmatch trial arm j (apec1621j) - "ulixertinib in patients with tumors with mapk pathway alterations", in poster discussion session, 5:00 - 7:00pm edt, on june 5th! learn more: 
Official Twitter account of the NCI Cancer Therapy Evaluation Program, providing updates to our trials research community. Privacy: https://t.co/47s9FxzVVe.